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Abstract
Background: KRAB-ZFPs (Krüppel-associated box domain-zinc finger proteins) are vertebrate-restricted
transcriptional repressors encoded in the hundreds by the mouse and human genomes. They act via an essential
cofactor, KAP1, which recruits effectors responsible for the formation of facultative heterochromatin. We have
recently shown that KRAB/KAP1 can mediate long-range transcriptional repression through heterochromatin
spreading, but also demonstrated that this process is at times countered by endogenous influences.
Method: To investigate this issue further we used an ectopic KRAB-based repressor. This system allowed us to
tether KRAB/KAP1 to hundreds of euchromatic sites within genes, and to record its impact on gene expression. We
then correlated this KRAB/KAP1-mediated transcriptional effect to pre-existing genomic and chromatin structures to
identify specific characteristics making a gene susceptible to repression.
Results: We found that genes that were susceptible to KRAB/KAP1-mediated silencing carried higher levels of
repressive histone marks both at the promoter and over the transcribed region than genes that were insensitive. In
parallel, we found a high enrichment in euchromatic marks within both the close and more distant environment
of these genes.
Conclusion: Together, these data indicate that high levels of gene activity in the genomic environment and the
pre-deposition of repressive histone marks within a gene increase its susceptibility to KRAB/KAP1-mediated
repression.
Keywords: KAP1, KRAB-zinc finger proteins, transcriptional repression, chromatin, heterochromatin, histone
modifications
Background
Gene expression is modulated through the alteration of
chromatin states by epigenetic regulators. Krüppel-asso-
ciated box zinc finger proteins (KRAB-ZFPs), which
together constitute the single largest group of transcrip-
tional repressors encoded by the human genome,
partake in this process [1-3]. The KRAB-ZFP family is
evolutionary recent and has expanded and diverged
through multiple rounds of gene and segment duplica-
tions, to give rise to more than three hundred and fifty
annotated members in humans [4-7]. Despite their
abundance, KRAB-ZFPs and their transcriptional targets
remain largely uncharacterized except for a few [8-10].
KRAB-ZFPs carry a C-terminal array of two to forty
C2H2 zinc finger motifs, each potentially capable of
recognizing a triplet of nucleotides in a sequence-speci-
fic manner [1], while their N-terminal KRAB domain
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recruits the KAP1 (KRAB associated protein 1) core-
pressor [11-14]. KAP1 (also named TIF1b, KRIP-1 or
TRIM28) binds KRAB and homotrimerizes through its
N-terminal RBCC (Ring finger/B box/Coiled-Coil)
domain, while its C-terminus acts as a scaffold for
various heterochromatin-inducing factors, such as
heterochromatin protein 1 (HP1), the histone methyl-
transferase ESET (also known as SetDB1), the nucleo-
some-remodeling and histone deacetylation (NuRD)
complex, the nuclear receptor corepressor complex 1
(N-CoR1) and, at least during early embryonic develop-
ment, de novo DNA methyltransferases [15-22]. This
results in local loss of histone acetylation, enrichment in
histone 3 lysine 9 trimethylation (H3K9me3) and
increased chromatin compaction [23,24].
Using chromatin immunoprecipitation (ChIP) and a
tiling array, KAP1 has been documented to bind more
than 7000 sites in a human testicular embryonal carci-
noma cell line [25]. A more recent publication addi-
tionally revealed that KAP1 chromatin targeting falls
into different categories, only a subset of which is
dependent on its RBCC domain and consequently on
its association with KRAB-ZFPs [26]. KAP1 is dynami-
cally associated with both heterochromatin and
euchromatin. It is thought to organize constitutive het-
erochromatin and to stimulate its propagation, as evi-
denced by its co-localization with HP1 in
pericentromeric heterochromatin domains [16,27].
Using a combination of gene trapping and a drug-con-
trollable KRAB-containing repressor, we recently
demonstrated that KRAB/KAP1 can induce long-range
repression through HP1-dependent heterochromatin
spreading [28]. However, while some promoters
located tens of kilobases (kb) from KAP1 docking sites
were silenced by this mechanism, others were resistant.
Here, we investigated the basis for this differential
behavior by comparing the genomic context and the
pre-existing levels of specific chromatin marks at
repressed and non-repressed genes. This analysis
revealed that genes most susceptible to KRAB/KAP1-
induced silencing were in genomic regions of high
gene activity. More specifically, repression was most
efficient at sites with increased levels of pre-existing
repressive histone marks at promoters and gene
bodies, embedded within gene-rich regions with high
levels of transcription.
Results
Characterization of thousands of KRAB/KAP1-targeted
gene traps
To study the impact of specific genomic features on
KRAB/KAP1-induced silencing, we used the recently
described trapping/silencing (TrapSil) system [28]. Here,
retrovirally-trapped cellular promoters are exposed to a
drug-regulated KRAB-containing repressor. The
tTRKRAB protein contains the KRAB domain of the
human KOX1 ZFP fused to the E. coli tetracycline
repressor (tTR), and binds to Tet operator sequences
(TetO) in a doxycycline (Dox)-controlled manner [29,30]
(Figure 1A). We engineered retroviral-based gene trap
vectors carrying tandem TetO repeats and a promoter-
less GFP-puromycin resistance fusion reporter. This
design predicts that i) reporter expression occurs from
the promoters of active genes targeted by the integrants
("trapping”), and ii) Dox withdrawal results in tTRKRAB
binding to the TetO sites present in the provirus, thus
exposing the trapped promoters to KRAB/KAP1-
mediated silencing ("silencing”) (Figure 1A). Using this
experimental setup, we previously observed that while
KRAB/KAP1 can act over long distances it is generally
more effective when bound 20 kb or less from a promo-
ter [28]. To study which other parameters might affect
KRAB/KAP1-induced repression, we infected tTRKRAB-
expressing HeLa cells with low doses of retroviral-based
TrapSil vectors to ensure that only one integrant per
cell was present. We made use of a combination of
murine leukemia viral (MLV)- and lentiviral (LV)- based
TrapSil vectors to obtain a greater diversity of targeted
genes, since MLV tends to integrate close to active tran-
scriptional start sites (TSS), while LV hits genes further
downstream in their transcribed region [31,32].
Since we were interested in elucidating differences
between KRAB/KAP1 repressible and non-repressible
promoters and genes, we reasoned that “all or none”
phenotypes would facilitate subsequent analyses.
Therefore, we selected cells in which trapped promo-
ters were highly active at baseline, and either strongly
repressed ("repressed clones” containing a “repressing
integrant”) or almost completely resistant to this pro-
cess ("non-repressed clones” containing a “non-repres-
sing integrant”) when the trans-repressor was allowed
to bind its target (Figure 1B). More specifically, we iso-
lated trapped integrants from a population of cells by
puromycin selection in the presence of Dox, which
impairs tTRKRAB binding and silencing. Then trapped
integrants were subjected to subsequent rounds of cell
sorting to isolate cells harboring gene traps with
repressible promoters and reporter genes. These
rounds first included the isolation of GFP negative
cells when tTRKRAB was allowed to bind (Dox-), fol-
lowed by the sorting out of GFP positive cells when its
recruitment was inhibited (Dox+) (Figure 1B). Isolation
of non-repressible genes was achieved by a similar
approach. However, trapped cell populations were cul-
tured in the presence of tTRKRAB binding (Dox-) and
GFP positive cells, which did not silence reporter
expression, were directly isolated after TrapSil vector
infections (Figure 1B).
Meylan et al. BMC Genomics 2011, 12:378
http://www.biomedcentral.com/1471-2164/12/378
Page 2 of 14
After the isolation of cell populations with differential
silencing phenotypes, we mapped proviral integration
sites, in order to identify the trapped genes. For this, we
combined linker-mediated PCR (LM-PCR) of proviral-
genomic junctions with massive parallel DNA
pyrosequencing [31,33,34]. The amplified sites were
mapped to the human genome with the FetchGWI soft-
ware [35], and the UCSC known gene annotation was
used to subsequently identify the trapped promoters
(Figure 1C). We previously described that about 1 in 15
Figure 1 Isolation of thousands of KRAB/KAP1 recruitment sites in genes with variable silencing phenotypes. (A) Experimental setup
used to target tTRKRAB to endogenous genes through the retroviral vector-based promoter trapping/silencing (TrapSil) system. TetO-containing
gene traps, which carry the promoterless GFP-puroR fusion reporter, are only expressed if they trap an actively transcribed gene. In the absence
of doxycycline (Dox-), binding of the ectopic tTRKRAB repressor to TetO mediates silencing by recruiting KAP1 and associated heterochromatin-
inducing factors. (B) Method used for isolating TrapSil HeLa cell subpopulations based on the effect of tTRKRAB binding on trapped gene
expression. Repressible (REP) clones exhibit silencing of the reporter gene upon tTRKRAB binding, whereas reporter transcription of non-
repressible clones (NREP) remains unaltered in this condition. (C) This table shows the outcome of the proviral integrant mapping and their
distribution relative to genes. Mapping to the genome was performed with FetchGWI. The determination of intragenic integration sites was
based on UCSC known genes. LVtotal and MLVtotal encompass all LV- and MLV -integrants. In addition, LV- and MLV- REP and NREP describe
the repressible and non-repressible subsets of each vector type.
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promoters trapped by MLV-TrapSil vectors were non-
repressed by tTRKRAB, compared with approximately 1
in 5 for those captured by LV-based vectors [28]. There-
fore, we isolated over 7000 integration sites, with an
intentional bias for non-repressed clones to obtain inte-
grant numbers comparable to their repressible counter-
parts. 69% of the promoter-trapping LV integrants
mapped within annotated genes, whereas only 54% of
their MLV counterparts did (Figure 1C, Additional File
1). This observation is in agreement with previous data
indicating that parental MLV as well as MLV-based
gene traps integrate in promoter proximal regions,
which are less well annotated than gene bodies, which
in turn are the preferential integration sites of LV and
LV-based traps [36,37]. Consistently, we mapped 6135
LV-TrapSil integrants to the genome, 4219 of which
were located within genes. In contrast, we only found
787 intragenic MLV-TrapSil integrants.
Prior to further analysis, we validated our experimen-
tal approach by deriving clones from each population.
All of the 32 clones analyzed exhibited the expected
silencing profile in flow cytometry measurements. More-
over, the clones comprised 10 non-repressed (LI I-X)
and 8 repressed (LR I-VIII) LV-TrapSil clones, in addi-
tion to 8 non-repressed (MI I-VIII) and 6 repressed
(MR I-VI) MLV-TrapSil clones, (Additional File 2). We
also used ChIP analysis to verify that non-repressed
genes properly recruited KAP1 and downstream effec-
tors to their tTRKRAB docking site, in a doxycycline-
dependent manner (Additional File 3). After this valida-
tion, we continued with the characterization of the
genomic context of our KRAB/KAP1 repressible or non-
repressible genes to find patterns correlating with silen-
cing efficiency.
Genomic environment of repressing and non-repressing
gene trap integrants
We characterized the genomic environment of the inte-
grants segregated according to their phenotype by using
ROC (Receiver Operator Characteristic) curve analysis
[38]. This type of analysis was previously used to iden-
tify the genomic features enriched around retroviral
integration sites. This study confirmed that both MLV
and LV preferentially integrate within transcriptionally
active regions, and that this effect is augmented when
integrants enabling reporter expression are selected [38].
In addition, this analysis also revealed that the effects of
different genomic features on integration can change
depending on the size of genomic segments in question
[38]. Therefore, we included genomic intervals ranging
from 0.1 kb to 10 Mb in our analyses.
In order to characterize the genomic features sur-
rounding the integrants in our different TrapSil groups,
we made use of the same approach. We first calculated
the area under the ROC curve, which is a common
measure of a predictor variable’s ability to discriminate
between two classes of events. In our case we compared
the average enrichment of a given feature at a set of
genomic sites (such as integration sites in our case) rela-
tive to that of a set of random matched control sites.
The read-out of this comparison is illustrated in color-
coded heatmaps, where each rectangle represents the
specific enrichment of a feature within the indicated
intervals of distance. The relative enrichment between
the integration and control site group is scored on a
scale from 0 to 1. 1 is scored when a specific feature is
enriched in the experimental integrants when compared
to matched controls, 0 is scored when the opposite is
true. A value of 0.5 indicates no difference between the
two groups. The patterns of the genomic features sur-
rounding the TrapSil integrant groups largely reflected
the preferential genomic environment associated with
either LV or MLV integrations (for values see Addi-
tional File 4). It included a preference for both retro-
viruses for active genes, in addition to their differential
targeting to gene bodies and promoters, respectively.
This is reflected by an increased enrichment of CpG
islands and DNase I sites at short intervals around MLV
integrants when compared to LV integrants. This differ-
ence is lost when larger intervals are included in the
ROC area calculation (Figure 2).
We then compared the ROC values, which are propor-
tional to the levels of genomic features at these sites,
between TrapSil groups harboring differential suscept-
ibilities to KRAB/KAP1-silencing. We did this by making
relative comparisons between a chosen reference and
other gene groups. The reference gene groups are indi-
cated by the symbol “—” within the whole results section.
Using this approach we compared the levels of specific
genomic features between the respective REP gene group
and their corresponding NREP counterpart. When statis-
tical differences were assessed, we found that LV-TrapSil
repressing integrants were located within gene-denser
genomic regions than non-repressible integrants (Figure
2). Furthermore, the environment of repressing LV inte-
grants was enriched in CpG and DNase I sites, as well as
in highly expressed genes (based on publicly available
microarray data), compared to that of non-repressing LV
integrants. While all the described parameters were sta-
tistically significantly different between repressible and
non-repressible LV traps, comparisons of their MLV-
TrapSil counterparts did not reach significant differences,
although it showed similar trends (Figure 2). Therefore, a
positive correlation between gene activity in the environ-
ment of the targeted transcriptional unit and efficient
KRAB/KAP1-mediated silencing is established. The lack
of significance between the MLV repressible and non-
repressible TrapSil groups could be due to smaller
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integrant numbers or could reflect the presence of other
uncharacterized features affecting KRAB/KAP1 recruit-
ment, including the on average closer proximity of MLV
integrants to promoters.
Genomic features of matched repressed and non-
repressed transcriptional units
Repressing integrants were on average closer to the
transcriptional start site of their targets, compared to
Figure 2 Characterization of the genomic environment of KRAB/KAP1-docking integrants. LV and MLV TrapSil integrants were split in
repressing (REP) and non-repressing (NREP) groups according to the effect of KRAB/KAP1 recruitment on the trapped promoters. The genomic
environment of the different proviral integrant groups was analyzed for the indicated genomic features by ROC curve analysis. This method
serves to calculate the relative abundance of a given genomic feature around the integrants of a group for specific intervals. The resulting values
are depicted in color-coded heat maps. 1 indicates that the specific feature is enriched in integrants, 0 means that it is depleted. Relative
abundance scores of repressing and non-repressing integrants were compared for each trapping vector subtype and the statistical method used
included the non-central chi-square test (** p < 0.01; *** p < 0.001). The different genomic feature categories tested were: “gene density”, with
all of the Refseq annotated genes; the “highly expressed genes” and “expressed genes” group, including genes expressed in the top 1/16th, or
the top 1/2 of all genes measured in a transcriptional profiling analysis; “start/end”, including the distance to the nearest transcriptional start
(TSS) or stop site; “gene start”, including the distance to the nearest TSS; “gene size” was the average size of the targeted genes and was only
analyzed for intragenic integrants; “GC content”, included the density of GC nucleotides, which are more abundant in gene-rich regions; “CpG
density”, contained the frequency of CpG dinucleotides, mostly present at promoters; “DNAse HS sites”, included the number of DNAse I
hypersensitive sites, frequently associated with gene regulatory regions.
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non-repressible integrants (Figure 2). This finding is
consistent with results from our previous analyses,
which revealed that KRAB/KAP1-induced repression
was more likely if gene traps were located closer to
trapped promoters [28]. Therefore, the described inte-
grant-centered analysis may suffer from potential biases
linked to this spatial factor. We thus repeated our ana-
lyses focusing on genes that had a minimal size of 20
kb, a single known TSS, and were frequently targeted by
our trapping vectors, that is, hit at least three times in
our series. We then classified these genes into three
subgroups according to their susceptibility to KRAB/
KAP1-induced silencing expressed as a function of the
distance between KRAB-docking integrant and trapped
promoter. This led to the identification of 70 genes that
supported long-range repression, that is, for which most
integrants located within 20 kb of the TSS were repres-
sing (group 1); 77 genes supporting limited range
repression, with silencing occurring mainly when inte-
grants were located 10 kb or less from the TSS (group
2); and 80 genes resistant to repression, where no signif-
icant silencing occurred irrespective of the distance
between the TSS and the KRAB/KAP1-docking sites
(group 3) (Figure 3A). Of note, there was no difference
between the expression patterns of these genes in differ-
ent tissues, indicating that these gene groups did not
differ in being essential or not for cellular maintenance
(data not shown).
The genomic context of the three gene groups was
reminiscent of observations made in the integrant-cen-
tered analysis (Figure 2), with genes from group 1 being
in gene-richer and transcriptionally more active environ-
ments, and surrounded by a higher density of DNase I
hypersensitivity sites (Figure 3B). These associations,
however, did not reach statistical significance. Impor-
tantly, no difference in distance between repressor bind-
ing site and the trapped promoter was apparent when
comparing the three groups, eliminating concerns about
this potential bias for subsequent analyses of these genes
(Figure 3B). When we examined the expression levels of
the different gene groups, we found that genes support-
ing long-range repression (group 1) were on average
more highly expressed than genes that did not enable
KRAB/KAP1-mediated repression (group 3) (Figure 3C).
Therefore, KRAB/KAP1-mediated silencing seems to be
more effective in regions of high gene activity. To further
consolidate this result, we assessed the levels of different
chromatin features, correlating with transcriptional acti-
vation or repression in our different gene groups.
Chromatin features of matched repressed and non-
repressed transcriptional units
We first assessed the levels of putative barrier elements
such as CTCF, H3.3/H2Az or chromatin modifiers in
the different groups [39-41]. This was achieved by utiliz-
ing published datasets, which were used to calculate the
relative abundance of these features by ROC curve ana-
lysis and by comparing these values between the groups.
There was no differential association with either one of
the three gene groups for the intervals tested (Addi-
tional File 5).
We then assessed the abundance of a series of histone
modifications present at an interval of 1, 10 or 100 kb
or 1 Mb around our promoters of interest. We first
measured the levels of posttranslational histone modifi-
cations correlating with active gene expression, includ-
ing histone H3 lysine 27 acetylation (H3K27ac), H2BK5
monomethylation (H2BK5me1), H3K4 mono- and tri-
methylation (H3K4me1, me3), H3K36me3 and
H4K20me1. For this we generated genome-wide histone
modification maps using a ChIP coupled to deep
sequencing (ChIPseq) approach in HeLa cells. Then we
used ROC curve-based heatmaps to obtain relative
enrichment values for the three groups. When the long-
range repressing group 1 was compared to the non-
repressing group 3 most of the active histone modifica-
tions were enriched in group 1 (Figure 4). This was the
case for smaller (10 kb) and larger intervals (100 kb, 1
Mb), consistent with the idea that KRAB/KAP1-repressi-
ble genes reside in regions of very active chromatin both
on a local and a more global scale (Figure 4A).
We then measured the levels of histone modifications
normally present at silent genes, such as H3K9me2/
me3, H3K27me3 and H4K20me3. For this we generated
histone modification maps by ChIPseq in HeLa cells or
relied on a published dataset for the distribution of
H3K27me3 in this cell line [39]. Furthermore, group 1
genes were comparatively less depleted in H3K9me3 at
the TSS and enriched in H4K20me3 at the promoter
and within a 10 kb distance from the TSS, compared
with genes from groups 2 and 3 (Figure 5). Therefore,
promoters sensitive to KRAB/KAP1-mediated repression
harbor increased levels of some silent histone marks,
which are embedded within a domain of very high gene
activity.
Discussion
Previous analyses on the mechanisms of KRAB/KAP1-
mediated gene regulation have mostly examined the
impact of this system on the expression of transfected
promoter-reporter units. Here, we investigated KRAB/
KAP1-induced changes within the context of endogen-
ous genes. Using a combination of promoter trapping
and drug-controllable KRAB/KAP1 recruitment, we pre-
viously observed that this complex, when docked to the
bodies of transcriptionally active genes, could induce
silencing over distances of several tens of kilobases [28].
However, we had also noted that repression was more
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Figure 3 Generation and characterization of matched gene groups displaying differential KRAB/KAP1 silencing phenotypes. (A)
Matched gene groups with differential KRAB/KAP1-silencing phenotypes. The cumulative histograms illustrate the distribution of repressible
(blue) and non-repressible (red) LV-TrapSil and MLV-TrapSil integrants in the transcribed region of genes trapped multiple times. Three groups
were distinguished based on the pattern of repressible and non-repressible integrants over 20 kb. Group 1 genes harbored mainly repressing
integrants ("long-range repression”), while group 3 contained mostly non-repressible integrants ("absence of repression”). Group 2 genes
exhibited an intermediate phenotype, with repressing integrants clustered over the first 10 kb of their transcribed region ("limited repression”).
(B) The three gene groups (group 1: “long-range repression”, group 2: “limited repression” and group 3: “absence of repression”) were analyzed
by ROC curves as described in Figure 2 for genomic features over various DNA stretches. (C) Comparison of mean expression levels of the three
gene groups based on publicly available microarray data. Group 1: “long-range repression”, group 2: “limited repression” and group 3: “absence
of repression”. Statistical comparisons were made with a non-parametric Wilcoxon test. P-Value Legend: ** p < 0.01.
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efficient if the distance between the effector and the
promoter was less than 20 kb. Furthermore, a significant
fraction of trapped promoters/KRAB docking loci
escaped these rules, suggesting other counteracting
influences. The present large-scale comparison of the
genomic features of KRAB/KAP1-responsive and KRAB/
KAP1-resistant transcriptional units identified by our
gene trap system reveals a positive correlation between
efficient KRAB/KAP1-mediated repression of trapped
promoters and i) a gene-richer and transcriptionally
more active genomic context, ii) a more euchromatic
environment, and iii) the pre-existence of some repres-
sive marks at and around the promoter.
Comparing KRAB/KAP1-repressed and non-
repressed genes gave no indication for a role of
putative obstacles to the spread of heterochromatin,
such as CTCF binding, accumulation of H3.3/H2Az or
recruitment of HATs (reviewed in [42,43]). This is
consistent with the observation that CTCF recruitment
to the HS4 region of the chicken b-globin locus can be
prevented without abrogating the barrier function of
this DNA sequence [44]. However, it is at odds with a
recent study presenting CTCF as a marker of transi-
tion between euchromatic and heterochromatic regions
[39]. A model reconciling these findings would be that
CTCF acts as an H3K27me3 heterochromatin-specific
barrier yet has no effect on H3K9me3-based hetero-
chromatin propagation. However, it should be empha-
sized that our analysis was limited to the transcribed
region of genes owing to our gene trap-based
Figure 4 Characterization of the chromatin environments of the matched gene groups with respect to active histone marks. (A) The
levels of specific posttranslational histone modifications around the promoters of the different gene groups were calculated over different DNA
intervals ranging from 1 kb to 1 Mb. The gene groups included group 1: “long-range repression”, group 2: “limited repression” and group 3:
“absence of repression” and ROC curve analyses was employed. Briefly, the illustrated heat maps, contain squares giving the relative abundance
of the studied histone mark. 1 is scored when the modification is enriched in the gene group when compared to a control group, while 0
indicates depletion of the mark. 0.5 is scored when there is no difference. Non-central chi-square statistical analysis compared differences
between the repressible group 1 and the non-repressible group 3. P-Value Legend: * p < 0.05; ** p < 0.01. The histone modifications in the
analysis included H3K27ac, H2BK5me1, H3K4me1, H3K4me3, H3K36me3, H4K20me1, which are mostly found within active chromatin. (B) Relevant
histograms representing the relative H3K4me3 and H3K36me3 values over 100 kb and 1 Mb, which reached statistically relevant differences
when all three gene groups were compared.
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approach, precluding overly general conclusions on the
possible role of barrier elements.
Although both repressed and non-repressed genes
were situated within euchromatic regions, as expected
from the promoter-trapping approach used for their
selection, we observed significant differences in both
their local and broader chromatin environments.
Repressed genes were in regions containing generally
higher levels of major euchromatin-associated marks
and higher levels of transcription compared with non-
repressed genes. Therefore, there is a positive correla-
tion between efficient KRAB/KAP1-silencing and high
gene activity. This is suggestive of a model whereby
genes situated in more heterochromatic environments
can only be highly expressed if endowed with an intrin-
sic ability to resist repressive influences, while genes
located in more euchromatic environments do not need
such protective mechanisms [45]. Consistently, in our
analysis KRAB/KAP1-resistant units were on average
closer to telomeres than their KRAB/KAP1-susceptible
counterparts, although this difference did not reach sta-
tistical significance (data not shown).
Genes repressed by the TrapSil system also carried
higher levels of the repressive marks H4K20me3 and
H9K9me3 at baseline at and around their promoters,
compared with their repression-resistant counterparts.
Noteworthy, these contrasting chromatin configurations
were not only observed when comparing a selected set
of multiply hit repressed and non-repressed genes (Fig-
ure 5), but were also present in the complete pools of
repressing and non-repressing integrants (Additional
File 6). Interestingly, a recent analysis of the chromatin
structure of zinc finger genes found that high levels of
both H3K36me3 and H3K9me3 co-localized at the 3’
exons of these genes [46]. Since KRAB-ZFP genes,
which belong to this gene family, are endogenous targets
of KRAB/KAP1-repression [25,47], we performed the
same analysis in our HeLa cell system and reproduced
the same result (Additional Files 7 and 8). Therefore,
the high levels of both H3K9me3 and H3K36me3 at
KRAB-ZFP gene bodies may be necessary for efficient
KRAB/KAP1-induced heterochromatin spreading. The
finding that the repressive H3K9me3 and the activating
H3K36me3 marks are not co-regulated further supports
this hypothesis [46], since high levels of H3K36me3,
which positively correlate with active transcription, may
independently enhance the spread of H3K9me3 at
KRAB-ZFP genes. This model is reminiscent of results
Figure 5 Characterization of the chromatin environments of the matched gene groups with respect to silent histone marks. (A) The
levels of histone marks associated with silent chromatin were analyzed at specific intervals around the promoters of the three gene groups
(group 1: “long-range repression”, group 2: “limited repression” and group 3: “absence of repression”). The calculations were based on ROC curve
analysis as described in Figure 4. Non-central chi-square statistical analysis compared differences between group 1 and group 2, and group 1
and group 3. The p-Value Legend is * p < 0.05; ** p < 0.01. The histone modifications in the analysis included H3K9me2, H3K9me3, H3K27me3
and H4K20me3, mainly associated with silent chromatin. (B) Relevant histograms representing relative H3K9me3 and H4K20me3 values over 1 kb
and 10 kb, which reached statistically relevant differences when the three groups were compared.
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obtained from the TrapSil analysis, where high levels of
both active and repressive histone marks can be seen in
genes that accommodate KRAB/KAP1-mediated hetero-
chromatin spreading and silencing.
A difference between genes targeted by our TrapSil
system and endogenous KRAB-ZFP genes lays in the
finding that the latter do not seem susceptible to
KRAB/KAP1-mediated long-range repression [28,46,47].
This may be due to the use of our ectopic repressor sys-
tem. Alternatively, certain endogenous promoters may
be resistant to KRAB/KAP1-induced heterochromatin
spreading. A possible factor in this process is the
H3K9me1/2 demethylase PHF8 [48]. Active H3K9
demethylation may prevent the heterochromatization of
KRAB-ZFP promoters and subsequent transcriptional
silencing. This idea is consistent with recent PHF8 gen-
ome-wide binding data that showed it locating to the
promoter regions of zinc finger-encoding genes [49].
Other mechanisms potentially involved in conferring
resistance to KRAB/KAP1-mediated silencing are sug-
gested by the analysis of genes that were hotspots of
proviral TrapSil targeting and carried both repressible
and non-repressible integrants (Additional File 9). In
this subgroup, the repressible integrants generally clus-
tered closer to the promoter than their non-repressible
counterparts, consistent with the overall observation
that silencing is most efficient when KRAB/KAP1 is
recruited in the proximity of the affected promoter. In
some cases, however, the distributions of repressible and
non-repressible integrants overlapped within the same
gene. This could reflect the differential susceptibilities of
the two alleles of a gene to KRAB/KAP1-mediated
repression, somewhat reminiscent of what is observed
with imprinting, a process that involves a KRAB-ZFP
[9,50]. Additionally, cells within a population may be
heterogeneous for the chromatin status of specific loci,
which in turn might impact on the consequences of
KRAB/KAP1 recruitment. Such a phenomenon would
be comparable to variegation, where particular genes are
differentially expressed amongst cells of an otherwise
apparently homogeneous population [51].
Conclusions
In summary, the present work indicates that the impact
of KRAB-mediated docking of KAP1 on the expression
of targeted genes is more variable than previously sus-
pected. It further reveals reciprocal influences between
the functional outcome of KRAB/KAP1 recruitment to
DNA and the chromatin features of the involved loci.
More broadly, the approach described in the present
study, which combined an analysis of the functional
consequences of exogenously introduced cis-acting
KRAB/KAP1-recruiting sequences with an examination
of the transcriptional activity, genomic context and
chromatin features of targeted loci, could be fruitfully
applied to the study other epigenetic regulators.
Methods
Vectors
pLV-tTR-KRAB-Red was previously described [52].
pLtTR-KRAB-NG95 was cloned through ligation of a
BamHI/XhoI digested MLV-based pNG95 [53] with a
compatible tTR-KRAB amplicon with BamHI/XhoI sites
added by PCR (primer sequences see Additional File
10). To construct LV- and MLV-based TrapSil vectors,
published gene trap vectors [37] were modified by PCR-
based mutagenesis (Stratagene mutagenesis kit). A BlpI
restriction site was introduced into the MLV U3 region
of 3’LTRs (MLV: BlpI Primers MLV Trap F/R - Addi-
tional File 10), whereas a SpeI site was introduced in the
LV U3 region of 3’LTR (Primers HIV Trap F/R - Addi-
tional File 10), these new sites were then used to insert
7 repeats of TetO. LV- and MLV-based particles were
produced and titered as described elsewhere http://tcf.
epfl.ch/page-6764-en.html. The WPRE of LV-TRAPSIL,
the GAG remnant of MLV-TRAPSIL, and the Albumin
gene served for proviral and cellular genome quantifica-
tion by Taqman.
Cell culture and Fluorescence activated cell sorting (FACS)
HeLa cells were grown under standard conditions. Dox-
ycycline (Sigma-Aldrich) was used at a concentration of
1 μg/mL. Clonal tTRKRAB-expressing HeLa cell lines
dsRK4 (pLV-tTR-KRAB-Red, LV-backbone) and
KiN1.25 (pLTetR-KRAB-NG95, MLV-backbone) were
derived after infection with pLV-tTR-KRAB-Red or
pTetR-KRAB-NG95, respectively. The LV based HeLa
dsRK4 clone contains approx. 15 vector copies as
titrated by Taqman and was used for MLV-TRAPSIL
assays while the MLV-based KiN1.25 clone contains 10
vector copies and was used for all LV-TRAPSIL assays.
In view of this mapping strategy, 2 × 108 dsRK4 or
KiN1.25 HeLa cells were infected with 1.6 × 106 MLV-
TrapSil or LV-TrapSil infectious particles, respectively,
with a multiplicity of infection of 0.04. Cells were sorted
based for GFP expression by using the Beckton Dickin-
son FACSVantage SE turbo Sorter with Diva Option.
Flow Cytometry analyses were performed on BD FACS-
can flow cytometer.
Quantitative PCR (qPCR)
qPCR reactions were carried out with a standard PCR
program in ABI PRISM 7900 HT in duplicates or tripli-
cate using either SYBR green detection 1× Power Sybr
or 1× Taqman Universal Mix, No AmpErase (Applied
Biosystems). Primers were used at a final concentration
of 100 nM. When SYBR analysis was performed, cycling
reactions were followed by a dissociation curve analysis
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to validate specificity of amplified products. The
increase in fluorescence was analyzed with the SDS soft-
ware, version 2.2.2 (Applied Biosystems). For all amplifi-
cation plots the baseline data were set with the
automatic cycle threshold function. Primer sequences
for all qPCR reactions are listed in Additional File 10.
Linker-mediated PCR (LM-PCR), 454 pyrosequencing and
data processing
LM-PCR was used to map integration sites following a
previously described protocol [31,33,34]. Briefly, 10 μg
of genomic DNA (DNeasy, Qiagen) was digested with
MseI. Fragments were ligated to a linker and were
digested with DpnI and SacI (LV-TrapSil) or SpeI
(MLV-TrapSil) to avoid contaminations with bacterial
plasmids and to avoid cloning of internal vector frag-
ments. Nested PCR then served to amplify TrapSil vec-
tor-gDNA junctions (Takara Advantage 2 kit).
Amplicons ranging between 100 and 400 bp were puri-
fied, quantified and sent for pyrosequencing at GATC
biotech (Konstanz, Germany). Raw sequences were
downloaded from the GATC biotech website and con-
verted to FASTA files. Sequences having exact pyrose-
quencing reaction primers (F: primer A; R: primer B,
Additional File 10) were selected and others discarded.
Selected sequences were then categorized according to
barcode for TrapSil vector type and integrant type (bar-
codes: LI: TGAC/AGTC; LR: CTGA; MI: TCGA/AGCT;
MR: GTAC). After classification, all primer sequences
and viral vector overhangs were trimmed yielding only
genomic DNA sequence. The 20 bases adjacent to pri-
mer B before trimming were used as tags for mapping
the inserts to the human genome assembly hg18. The
mapping was done using FetchGWI tolerating at most 2
mismatches [35].
Integration site mapping in genes: Integrant orienta-
tion was annotated as determined during sequence pro-
cessing. UCSC known gene [54] were downloaded from
UCSC tables with transcript start (Tsx), transcript end
(Tsend) and gene orientation. Only integrants mapping
with correct orientation within a gene were mapped
relative to it. In a second step, a non-redundant gene
list was generated (from the original UCSC Gene list)
using an aggressive clustering strategy, which groups all
transcripts that directly or indirectly (through other
transcripts) overlap on the same strand of the same
chromosome. In the non-redundant gene list we
recorded the 5’most Tsx position and the 3’most Tsend
position for each cluster. For analysis of the integrant
distance to gene promoters, we considered only inte-
grants falling within the transcribed region of the same
gene. Files containing integration sites (sequence-map-
ping from Insipid, LV_LUI (LV irrepressible), LV_LUR
(LV repressible), MLV_MUI (MLV irrepressible),
MLV_MUR (MLV_repressible)) and gene groups (20 KB
promoter classes with at least 3 integration sites: group
1: “long-range repressible), group 2: “short-range repres-
sible”, group 3: “long-range irrepressible”) can be found
under http://ccg.vital-it.ch/KAP1/.
Receiver Operator Characteristic (ROC) curve analysis
Data analysis was based on a “nested case control” strat-
egy using a collection of TSS characterized by a given
behavior with respect to repression along with control
sites sampled from the genome to make inferences
about the probability of a TSS to display a given
response to repression based on genomic/epigenetic fea-
tures characterizing its environment. More detailed
description of statistical basis for this analysis can be
found in [38]. Data were analyzed using the R language
and environment for statistical computing/graphics ver-
sion 2.3.0 and several contributed packages. Empirical
ROC curve areas were calculated for datasets that used
random genomic controls, in which case each TSS of a
cluster was compared only with its matched controls to
determine the proportions of controls whose values
equaled or exceeded that of TSS [55]. Annotations of
genomic features were obtained as described previously
[38]; the chromatin features analyzed came from ChIP-
seq data generated in this and other studies [39-41].
Chromatin immunoprecipitation (ChIP) and ChIP followed
by sequencing (ChIP-Seq)
ChIP reactions were performed according to published
protocols with minor modifications (http://www.milli-
pore.com/userguides/tech1/mcproto407 and http://
cshprotocols.cshlp.org/cgi/content/full/2009/6/pdb.
prot5237), using antibodies listed in Additional File 11,
either native or pre-bound to beads. For Histone modifi-
cations, 2 × 107 HeLa cells were trypsinized and resus-
pended in MNase buffer. 1 U MNase (Roche) was added
for 10 min and adding EDTA to a final of 10 mM
arrested the nuclease reaction. Chromatin was sonicated
with a Branson digital sonicator (model 250) on ice
three times for 20 s and then dialyzed against RIPA
with AEBSF protease inhibitor 0.2 mM for 1 h. The
chromatin was pelleted after dialysis; glycerol was added
to the supernatant to a final 5% concentration and the
chromatin was stored at -80°C. 500 ul was incubated
with AB-specific pre-coated beads over night (IP). Com-
plexes were washed, eluted, purified, precipitated and
resuspended in 50 ul H2O. For KAP1 ChIPs, approxi-
mately 2 × 107 cells were cross-linked with 1% formal-
dehyde for 8 min at RT, quenched by adding glycine
and rinsed with PBS, before shearing by sonication with
a Branson digital sonicator (model 250) on ice four
times for 20 s at 30% intensity. 100 μl of sonicated chro-
matin was directly de-crosslinked and used as the total
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input (TI) reference in qPCR analysis at a dilution of
1:100. 100 μl of sonicated chromatin was used for each
ChIP reaction and was diluted in 900 μl dilution buffer
and precleared with 80 μl salmon-sperm DNA protein
A agarose beads (Upstate). Chromatin-antibody com-
plexes were captured washed and eluted with 100 mM
NaHCO3, 1% SDS. Cross-links between DNA and pro-
teins were reversed by addition of NaCl and incubation
at 65°C. DNA was precipitated after incubation with
RNase A (Sigma) and Proteinase K (Roche) and resus-
pended in 50 μl H2O and subjected to qPCR analysis.
qPCR is described above and primers are listed in Addi-
tional File 10. Negative control reactions without anti-
body were run for each sample and in all cases gave
negligible results. To validate the relative enrichment of
proteins or specific histone modifications at a given
sequence a ratio between the relative quantities of IP
and TI was established.
The sequencing libraries from all ChIP products
were prepared using the ChIP-seq Sample Preparation
Kit (Illumina; San Diego, California, USA; Cat. No. IP-
102-1001) according to the protocol supplied with the
reagents and using 10 ng of ChIP sample quantified
using the Qubit fluorometer (Invitrogen; Carlsbad,
California, USA). One lane of each library was
sequenced on the Illumina Genome Analyzer IIx using
the Single-Read Cluster Generation Kit v2 (Cat. No.
FC-103-2001) and 36 Cycle Sequencing Kits v3 and v4
(Cat. Nos. FC-104-3002 and FC-104-4002). Data were
processed using the Illumina Pipeline Software v1.5.1.
Illumina GAII data were mapped to the genome with
Bowtie http://bowtie-bio.sourceforge.net/index.shtml.
All output files were converted to processable file for-
mats (SGA) for subsequent bioinformatics analysis
described below. Enrichment of genomic and chroma-
tin features was assessed with the ChIPcor web-based
tool http://ccg.vital-it.ch/chipseq/chip_cor.html. All
files were converted into SGA format, settings
included: sort input: on, strand option: oriented for
references files (gene clusters TSS and poly-A sites)
and any for all target features, range was set at -40 kb
to +40 kb, window size was at 500/50 (for graphic or
statistical analysis) and cut-off value was 1. Raw and
processed sga files can also be found under http://ccg.
vital-it.ch/KAP1/ and were used as follows: “SGA files
for Zhao-produced CTCF and H3K27me3 genome
wide” include HeLa-CTCF.sga.gz, HeLa-H3K27me3.sga.
gz data; “H3.3-H2A.Z double ChIP (Zhao et al)” con-
tain GSM335958.sga.gz files; “SGA files from genome-
wide mapping of HATs and HDACs in human CD4+
T cells” [41]: contain CD4-Tip60.sga.gz; “SGA files for
histone modification profiles (ChIP-Seq data)": con-
tains H3K27ac: H3K27acpf.sga, H2BK5me1:
H2BK5me1pf.sga, H3K4me1: H3K4me1pf.sga,
H3K4me3: H3K4me3p.sga, H3K36me3: H3K36me3b.
sga, H4K20me1: H4K20me1b.sga, H3K9me2:
H3K9me2p.sga, H3K9me3: H3K9me3pf.sga,
H4K20me3: H4K20me3b.sga.
Microarray data
HU133a arrays for HeLa cells were downloaded from
GEO/NCBI [56,57] and data were extracted and normal-
ized using RNA Robust Multichip Average (Quantile
normalization) [58]. Specific gene expression scores
were extracted and normalized average values for 4 dif-
ferent arrays were calculated. Statistical comparisons
were done with the non-parametric Wilcoxon test.
Additional material
Additional file 1: List of mapped integrants and integrant gene
groups.
Additional file 2: KRAB/KAP1 repression profiles from clones
isolated from repressible and non-repressible TrapSil populations.
Reporter gene activity in the presence and absence of doxycycline (Dox)
was monitored in clones derived from repressible and non-repressible
TrapSil populations.
Additional file 3: KAP1 and H3K9me3 are present at non-repressible
clones in the presence of repressor binding. Chromatin-
immunoprecipitation (ChIP) in combination with qPCR was used to verify
proper KAP1 recruitment to gene traps in the absence of doxycycline in
non-repressible clones. In addition, levels of H3K9me3 monitored the
enzymatic activity of the KRAB/KAP1 silencing complex. The relative
enrichment was calculated as a percentage of the total input (% of total
input).
Additional file 4: Values from Receiver Operator Characteristic
(ROC) curve analysis.
Additional file 5: Heterochromatin barrier elements in the
environment of the matched gene groups. The relative level of barrier
elements was assayed in the three gene groups (group 1: “long-range
repression”, group 2: “limited repression” and group 3: “absence of
repression”). Calculations were based on ROC curves as described in
Figure 3 and included various DNA stretches around the promoters of
the different gene groups. Non-central chi square statistical analysis
indicated no differences between the groups. The features considered in
the analysis were (A) Histone variants associated with active remodeling
(H3.3, H2Az), (B) CTCF or (C) chromatin modifiers, such as the histone
acetyltransferases p300, TIP60, PCAF and MOF, in addition to the histone
deacetylases HDAC1, 2, 3, and 6. The genome-wide binding data for
these factors came from published work in HeLa cells (H3.3, H2Az, p300)
or CD4 cells (TIP60, PCAF, MOF, HDAC1, 2, 3 and 6).
Additional file 6: Characterization of the chromatin environment of
all KRAB/KAP1-docking integrants. LV and MLV TrapSil integrants were
split in repressing (REP) and non-repressing (NREP) groups according to
the effect of KRAB/KAP1 recruitment on the trapped promoters. The
chromatin environment of the different proviral integrant groups was
analyzed for the indicated features by ROC curve analysis. (A) The histone
modifications in the analysis included H3K27ac, H2BK5me1, H3K4me1,
H3K4me3, H3K36me3, H4K20me1, which are mostly found within active
chromatin. (B) The histone modifications in this analysis included
H3K9me2, H3K9me3, H3K27me3 and H4K20me3, mainly associated with
silent chromatin. Non-central chi-square statistical analysis compared
differences between the integrant groups with the differential silencing
phenotypes. P-Value Legend: * p < 0.05; ** p < 0.01; *** p < 0.001.
Additional file 7: Characterization of the chromatin state of KRAB-
ZFP genes. Illustration of H3K9me3 and H3K36me3 enrichments at
KRAB-ZFP gene bodies in HeLa cells. KRAB-ZFP gene lengths were
equalized by division into 40 bins and included a 2 kb flanking region
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on both sides of the genes. See Additional File 8 for the list of KRAB-ZFP
genes, which were included in the analysis.
Additional file 8: List of known and putative KRAB-ZFP genes
included in the analysis.
Additional file 9: Genes with multiple TrapSil integrants of different
silencing phenotypes. Graphic representation of 6 genes, where
multiple TrapSil integrations of different phenotypes have occurred:
calnexin precursor (CANX), heterogeneous nuclear ribonucleoprotein A2/
B1 (HNRNPA2B1), karyopherin beta 1 (KPNB1), nucleophosmin 1 (NPM1),
Y-box binding protein 1 (YBX1), laminin alpha 5 (LAMA5). The integrants
with a repressible phenotype are depicted as black lines above the
baseline (y = 0), whereas the non-repressible counterparts are depicted
as light grey lines below the baseline. Some intragenic sites carried
multiple but distinct proviral integrants and subsequently harboured
more than 1 integrant count (see y-axis).
Additional file 10: List of primers used in this study.
Additional file 11: List of antibodies used in this study.
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